CLPT
ClearPoint Neuro, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$13.96
−0.64%Margins
Gross margin
62.6%
EBITDA margin
-64.9%
EBIT margin
-73.4%
Net margin
-81.8%
FCF margin
-74.0%
-320.8%
Return on equity
-39.8%
Return on assets
-41.5%
Return on invested capital
0.47x
Asset turnover
-$30.2M
Cash from operations
$0.96
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026